Sign in

    Olivia Miles

    Research Analyst at Robert W. Baird & Co.

    Olivia Miles is an Equity Research Analyst at Robert W. Baird & Co., specializing in institutional equities research with a focus on select sectors within the firm’s coverage universe. She analyzes performance and growth prospects of specific companies across industries, leveraging Baird's extensive research platform that covers over 700 stocks. With a strong track record in delivering actionable insights, Olivia has established her reputation for objective and timely research, though quantifiable performance metrics such as returns and analyst rankings are not publicly available. She began her analytical career at Baird and holds FINRA securities licenses required for the role, maintaining professional standards expected at a leading employee-owned research firm.

    Olivia Miles's questions to Privia Health Group (PRVA) leadership

    Olivia Miles's questions to Privia Health Group (PRVA) leadership • Q2 2025

    Question

    Olivia Miles, on for Michael, asked if the narrowing of ACO REACH risk corridors is catalyzing new prospective physician partner relationships for Privia.

    Answer

    CEO Parth Mehrotra agreed this is a great question, stating that as the economic gap between ACO REACH and MSSP Enhanced Track narrows, it bodes well for Privia. The change reduces the differentiation for competitors focused solely on REACH, creating opportunities for Privia to talk with practices that may have partnered with others. He noted this shift creates good tailwinds for Privia's model, which has excelled in the MSSP program.

    Ask Fintool Equity Research AI

    Olivia Miles's questions to Privia Health Group (PRVA) leadership • Q3 2024

    Question

    Olivia Miles, on for Michael Ha at Baird, asked about the drivers behind the 14,000 increase in Medicaid lives and questioned the company's overall view and model for achieving profitability in Medicaid value-based care.

    Answer

    CEO Parth Mehrotra explained the growth in Medicaid lives was driven by both new provider signings and new Medicaid managed care contracts. He stressed the flexibility of the model, noting that 100% of these lives are in upside-only arrangements, avoiding downside risk in a challenging population. The strategy is to convert low fee-for-service payments into additional revenue streams like care coordination fees and quality bonuses, adding value without taking on significant risk.

    Ask Fintool Equity Research AI